Silverfin false false 30/09/2024 01/10/2023 30/09/2024 Mrs Kathryn Alexandra Pratt 10/03/2021 Mr Richard Pratt 29/05/2014 24 March 2025 The principal activity of the company is the provision of medical information technology and computer services activities. 09061703 2024-09-30 09061703 bus:Director1 2024-09-30 09061703 bus:Director2 2024-09-30 09061703 2023-09-30 09061703 core:CurrentFinancialInstruments 2024-09-30 09061703 core:CurrentFinancialInstruments 2023-09-30 09061703 core:ShareCapital 2024-09-30 09061703 core:ShareCapital 2023-09-30 09061703 core:RetainedEarningsAccumulatedLosses 2024-09-30 09061703 core:RetainedEarningsAccumulatedLosses 2023-09-30 09061703 core:OfficeEquipment 2023-09-30 09061703 core:OfficeEquipment 2024-09-30 09061703 bus:OrdinaryShareClass1 2024-09-30 09061703 2023-10-01 2024-09-30 09061703 bus:FilletedAccounts 2023-10-01 2024-09-30 09061703 bus:SmallEntities 2023-10-01 2024-09-30 09061703 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 09061703 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 09061703 bus:Director1 2023-10-01 2024-09-30 09061703 bus:Director2 2023-10-01 2024-09-30 09061703 core:OfficeEquipment core:TopRangeValue 2023-10-01 2024-09-30 09061703 2022-10-01 2023-09-30 09061703 core:OfficeEquipment 2023-10-01 2024-09-30 09061703 bus:OrdinaryShareClass1 2023-10-01 2024-09-30 09061703 bus:OrdinaryShareClass1 2022-10-01 2023-09-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 09061703 (England and Wales)

KERNOW HEALTH SOLUTIONS LTD

Unaudited Financial Statements
For the financial year ended 30 September 2024
Pages for filing with the registrar

KERNOW HEALTH SOLUTIONS LTD

Unaudited Financial Statements

For the financial year ended 30 September 2024

Contents

KERNOW HEALTH SOLUTIONS LTD

BALANCE SHEET

As at 30 September 2024
KERNOW HEALTH SOLUTIONS LTD

BALANCE SHEET (continued)

As at 30 September 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 3 409 655
409 655
Current assets
Debtors 4 1,931 571
Cash at bank and in hand 1,014 622
2,945 1,193
Creditors: amounts falling due within one year 5 ( 30,122) ( 30,074)
Net current liabilities (27,177) (28,881)
Total assets less current liabilities (26,768) (28,226)
Net liabilities ( 26,768) ( 28,226)
Capital and reserves
Called-up share capital 6 1,000 1,000
Profit and loss account ( 27,768 ) ( 29,226 )
Total shareholders' deficit ( 26,768) ( 28,226)

For the financial year ending 30 September 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of Kernow Health Solutions Ltd (registered number: 09061703) were approved and authorised for issue by the Board of Directors on 24 March 2025. They were signed on its behalf by:

Mr Richard Pratt
Director
KERNOW HEALTH SOLUTIONS LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 September 2024
KERNOW HEALTH SOLUTIONS LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 September 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Kernow Health Solutions Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Lowin House, Tregolls Road, Truro, TR1 2NA, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors acknowledge the company's net current liability position at the balance sheet date. The "other creditors" balance of £28,501 (2023 : £28,489) represents amounts owed to the directors. As the directors do not intend to call this debt in until the company can afford to pay it, the directors have satisfied themselves that the company is a going concern.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Revenue from services is recognised as they are delivered.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a [straight-line, reducing balance] basis over its expected useful life, as follows:

Office equipment 4 years straight line
Financial instruments

The company holds the following financial instruments:

• Short term trade and other debtors and creditors;
• Cash and bank balances.

All financial instruments are classified as basic.

Recognition and measurement

The company has chosen to apply the recognition and measurement principles in FRS102.

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument and derecognised when in the case of assets, the contractual rights to cash flows from the assets expire or substantially all the risks and rewards of ownership are transferred to another party, or in the case of liabilities, when the company’s obligations are discharged, expire or are cancelled.

Except for bank loans, such instruments are initially measured at transaction price, including transaction costs, and are subsequently carried at the undiscounted amount of the cash or other consideration expected to be paid or received, after taking account of impairment adjustments.

Bank loans are initially measured at transaction price, including transaction costs, and are subsequently carried at amortised cost using the effective interest method.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 0 1

3. Tangible assets

Office equipment Total
£ £
Cost
At 01 October 2023 2,403 2,403
At 30 September 2024 2,403 2,403
Accumulated depreciation
At 01 October 2023 1,748 1,748
Charge for the financial year 246 246
At 30 September 2024 1,994 1,994
Net book value
At 30 September 2024 409 409
At 30 September 2023 655 655

4. Debtors

2024 2023
£ £
Trade debtors 1,386 88
Other debtors 545 483
1,931 571

5. Creditors: amounts falling due within one year

2024 2023
£ £
Other taxation and social security 132 122
Other creditors 29,990 29,952
30,122 30,074

6. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
1,000 ORD ordinary shares of £ 1.00 each 1,000 1,000